Skip to main content
Log in

Incidence and Nature of Medication Errors in Neonatal Intensive Care with Strategies to Improve Safety

A Review of the Current Literature

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Neonates are highly vulnerable to medication errors because of their extensive exposure to medications in the neonatal intensive care unit (NICU), the general lack of evidence on pharmacotherapeutic interventions in neonates and the lack of neonate-specific formulations. We searched PubMed and EMBASE to identify relevant original studies published in the English language. Eleven studies were identified on the frequency of medication errors in the NICU. The highest rate was 5.5 medication errors per 100 prescriptions; however, medication error rates varied widely between studies, partly due to differences in the definition of an error and the rigor of the method used to identify medication errors. Furthermore, studies were difficult to compare because medication error rates were calculated differently. Most studies did not assess the potential clinical impact of the errors. The majority of studies identified dose errors as the most common type of error. Computerised physician order entry and interventions by clinical pharmacists (e.g. the participation of pharmacists in ward rounds and review of patients’ prescriptions prior to dispensing) were the most common interventions suggested to improve medication safety in the NICU. However, only very limited data were available on evaluation of the effects of such interventions in NICUs. More research is needed to determine the frequency and types of medication errors in NICUs and to develop evidence-based interventions to improve medication safety in the NICU setting. Some of these research efforts need to be directed to the establishment of clear definitions of medication errors and agreement on the methods that should be used to measure medication error rates and their potential clinical impact.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug Saf 2005; 28(3): 251–61

    Article  PubMed  Google Scholar 

  2. Morselli PL. Clincial pharmacokinetics in neonates. Clin Pharmacokinet 1976; 1(2): 81–98

    Article  PubMed  CAS  Google Scholar 

  3. Aranda JV, Portuguez-Malavasi A, Collinge JM, et al. Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther 1982; 5(3–4): 173–84

    PubMed  CAS  Google Scholar 

  4. Koren G. Therapeutic drug monitoring principles in the neonate. Clin Chem 1997; 43(1): 222–7

    PubMed  CAS  Google Scholar 

  5. Conroy S, Mclntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonatal Med 2005 Apr; 10(2): 115–22

    Article  PubMed  Google Scholar 

  6. Conroy S, Mclntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999 Mar; 80(2): F142–4

    Article  PubMed  CAS  Google Scholar 

  7. Celeste HP. Therapeutic drug monitoring in neonates. Neonatal Network 1995; 14(2): 21–6

    Google Scholar 

  8. Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: from neonates to adolescents. Adv Drug Deliv Rev 2006 Apr 20; 58(1): 4–14

    Article  PubMed  CAS  Google Scholar 

  9. McClead Jr RE, Menke JA. Neonatal iatrogenesis. Adv Pediatr 1987; 34: 335–56

    PubMed  Google Scholar 

  10. O’Donnell CP, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002 Nov; 110(5): e52

    Article  PubMed  Google Scholar 

  11. Barr J, Brenner-Zada G, Heiman E, et al. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol 2002 Feb; 19(2): 67–72

    Article  PubMed  Google Scholar 

  12. Anderson BJ, Ellis JF. Common errors of drug administration in infants: causes and avoidance. Paediatr Drugs 1999 Apr; 1(2): 93–107

    Article  PubMed  CAS  Google Scholar 

  13. Gray JE, Goldmann DA. Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed 2004 Nov; 89(6): F472–3

    Article  PubMed  CAS  Google Scholar 

  14. Mclntyre J, Choonara I. Drug toxicity in the neonate. Biol Neonate 2004; 86(4): 218–21

    Article  Google Scholar 

  15. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001 Apr 25; 285(16): 2114–20

    Article  PubMed  CAS  Google Scholar 

  16. Simpson JH, Lynch R, Grant J, et al. Reducing medication errors in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 2004 Nov; 89(6): F480–2

    Article  PubMed  CAS  Google Scholar 

  17. Vincer MJ, Murray JM, Yuill A, et al. Drug errors and incidents in a neonatal intensive care unit: a quality assurance activity. Am J Dis Child 1989 Jun; 143(6): 737–40

    PubMed  CAS  Google Scholar 

  18. Myers TF, Venable HH, Hansen JA. Computer-enhanced neonatology practice evolution in an academic medical center. NICU Clinical Effectiveness Task Force. J Perinatol 1998 Nov; 18 (6 Pt 2 Su): S38–44

    PubMed  CAS  Google Scholar 

  19. Larsen GY, Parker HB, Cash J, et al. Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients. Pediatrics 2005 Jul; 116(1): e21–5

    Article  PubMed  Google Scholar 

  20. Carroll AE, Tarczy-Hornoch P, O’Reilly E, et al. Resident documentation discrepancies in a neonatal intensive care unit. Pediatrics 2003 May; 111 (5 Pt 1): 976–80

    Article  PubMed  Google Scholar 

  21. Raju TN, Kecskes S, Thornton JP, et al. Medication errors in neonatal and paediatric intensive-care units. Lancet 1989 Aug 12; 2(8659): 374–6

    Article  PubMed  CAS  Google Scholar 

  22. Suresh G, Horbar JD, Plsek P, et al. Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics 2004 Jun; 113(6): 1609–18

    Article  PubMed  Google Scholar 

  23. Ross LM, Wallace J, Paton JY. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child 2000 Dec; 83(6): 492–7

    Article  PubMed  CAS  Google Scholar 

  24. Chappell K, Newman C. Potential tenfold drug overdoses on a neonatal unit. Arch Dis Child Fetal Neonatal Ed 2004 Nov; 89(6): F483–4

    Article  PubMed  CAS  Google Scholar 

  25. Cordero L, Kuehn L, Kumar RR, et al. Impact of computerized physician order entry on clinical practice in a newborn intensive care unit. J Perinatol 2004 Feb; 24(2): 88–93

    Article  PubMed  Google Scholar 

  26. Koren G, Barzilay Z, Greenwald M. Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics 1986 Jun; 77(6): 848–9

    PubMed  CAS  Google Scholar 

  27. Lucas AJ. Improving medication safety in a neonatal intensive care unit. Am J Health Syst Pharm 2004 Jan 1; 61(1): 33–7 513

    PubMed  Google Scholar 

  28. Blum KV, Abel SR, Urbanski CJ, et al. Medication error prevention by pharmacists. Am J Hosp Pharm 1988 Sep; 45(9): 1902–3

    PubMed  CAS  Google Scholar 

  29. Folli HL, Poole RL, Benitz WE, et al. Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics 1987 May; 79(5): 718–22

    PubMed  CAS  Google Scholar 

  30. Condren ME, Haase MR, Luedtke SA, et al. Clinical activities of an academic pediatric pharmacy team. Ann Pharmacother 2004 Apr; 38(4): 574–8

    Article  PubMed  Google Scholar 

  31. Krupicka MI, Bratton SL, Sonnenthal K, et al. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 2002 Apr; 30(4): 919–21

    Article  PubMed  Google Scholar 

  32. Flynn EA, Barker KN, Pepper GA, et al. Comparison of methods for detecting medication errors in 36 hospitals and skillednursing facilities. Am J Health Syst Pharm 2002 Mar 1; 59(5): 436–46

    PubMed  Google Scholar 

  33. Wong IC, Ghaleb MA, Franklin BD, et al. Incidence and nature of dosing errors in paediatric medications: a systematic review. Drug Saf 2004; 27(9): 661–70

    Article  PubMed  Google Scholar 

  34. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998 Oct 21; 280(15): 1311–6

    Article  PubMed  CAS  Google Scholar 

  35. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999 Jul; 6(4): 313–21

    Article  PubMed  CAS  Google Scholar 

  36. Potts AL, Barr FE, Gregory DF, et al. Computerized physician order entry and medication errors in a pediatric critical care unit. Pediatrics 2004 Jan; 113 (1 Pt 1): 59–63

    Article  PubMed  Google Scholar 

  37. King WJ, Paice N, Rangrej J, et al. The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003 Sep; 112 (3 Pt 1): 506–9

    Article  PubMed  Google Scholar 

  38. Kaushal R, Barker KN, Bates DW. How can information technology improve patient safety and reduce medication errors in children’s health care? Arch Pediatr Adolesc Med 2001 Sep; 155(9): 1002–7

    PubMed  CAS  Google Scholar 

  39. Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003 Apr; 111 (4 Pt 1): 722–9

    Article  PubMed  Google Scholar 

  40. Han YY, Carcillo JA, Venkataraman ST, et al. Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system. Pediatrics 2005 Dec; 116(6): 1506–12

    Article  PubMed  Google Scholar 

  41. Copelan D, Appel J. Implementation of an enteral nutrition and medication administration system utilizing oral syringes in the NICU. Neonatal Netw 2006 Jan; 25(1): 21–4

    Article  PubMed  Google Scholar 

  42. Zenk KE. How you can serve as pharmacist to the neonate. Pharm Times 1980 Nov; 46(11): 40–9

    PubMed  CAS  Google Scholar 

  43. Johnson FL, Winship III HW, Trinca CE, et al. Neonatal medication surveillance by the pharmacist. Am J Hosp Pharm 1977 Jun; 34(6): 609–12

    PubMed  CAS  Google Scholar 

  44. Khoo GP, Bolton O. Neonatal and paediatric intensive care. Hospital Pharmacist 2003 Feb; 10: 66–71

    Google Scholar 

  45. Poley MJ, Bouwmans CA, Hanff LM, et al. Efficiency of different systems for medication distribution in an academic children’s hospital in The Netherlands. Pharm World Sci 2004 Apr; 26(2): 83–9

    Article  PubMed  Google Scholar 

  46. Fontan JE, Maneglier V, Nguyen VX, et al. Medication errors in hospitals: computerized unit dose drug dispensing system versus ward stock distribution system. Pharm World Sci 2003 Jun; 25(3): 112–7

    Article  PubMed  Google Scholar 

  47. Dean B, Schachter M, Vincent C, et al. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002 Apr 20; 359(9315): 1373–8

    Article  PubMed  Google Scholar 

  48. Schneider MP, Cotting J, Pannatier A. Evaluation of nurses’ errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci 1998 Aug; 20(4): 178–82

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used in the preparation of this article. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Indra Chedoe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chedoe, I., Molendijk, H.A., Dittrich, S.T.A.M. et al. Incidence and Nature of Medication Errors in Neonatal Intensive Care with Strategies to Improve Safety. Drug-Safety 30, 503–513 (2007). https://doi.org/10.2165/00002018-200730060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200730060-00004

Keywords

Navigation